E - Index
In this guide
In this guideOn this page
Skip the menu of subheadings on this page.
Subject: ECETOC |
Year |
Page |
Monograph on Aneuploidy |
1997 |
78 |
workshop on use of T25 in chemical carcinogen evaluation |
2001 |
141 |
Subject: Electronic nicotine, or non-nicotine, delivery s ystems (e-cigarettes), potential toxicological risks from |
Year |
Page |
Aerosol particle fraction, characterisation of |
2017 |
28 |
Carcinogenicity data, overview of available |
2018 |
50 |
Exposure to EN(N)DS aerosols, metals and solvents, silicon/silicate particles, nicotine toxicity |
2018 |
28 |
Exposure to EN(N)DS aerosols - known constituents and potential adverse health outcomes arising from |
2020 |
9 |
Flavouring compounds, framework for risk assessment of |
2019 |
18 |
Genotoxic risk, potential |
2018 |
43 |
Nicotine salts in, a summary of data published to date |
2020 |
34 |
Statement on, |
2020 |
6 |
Toxicological risks, potential |
2019 |
52 |
Addendum to the statement on |
2021 |
26 |
Subject: Endocrine disrupting chemicals |
Year |
Page |
Definition for regulatory purposes |
2010 |
11 |
Risk assessment of |
2019 |
17 |
Subject: Endosulfan |
Year |
Page |
Endosulfan, pentachlorobenzene and chlordecone in the infant diet |
2013 |
18 |
Subject: Energy drinks |
Year |
Page |
in the diet of children and adolescents, final statement on |
2019 |
10 |
interim statement on |
2018 |
29 |
Subject: |
Year |
Page |
carcinogenicity in laboratory rodents |
1993 |
50 |
in vitro and in vivo carcinogenicity |
1992 |
56 |
Subject: Environmental Tobacco Smoke (ETS) and lung cancer |
Year |
Page |
COC statement on |
1997 |
88 |
consideration of paper by Enstrom JE and Kabat GC (2003). British Medical Journal volume 326, 1057-1066 |
2003 |
191 |
Subject: Environmental mutagens |
Year |
Page |
Significance of environmental mutagenesis |
2004 |
141 |
Subjects: Enzymes |
Year |
Page |
Amano 90 – submission to COT |
2000 |
15 |
Enzyme submission COT |
2001 |
9 |
Chymosin – Enzyme submission COT |
1999 |
16 |
Enzyme submission COT, modified recovery and purification |
2000 |
16 |
Enzyme submission –derived from GM aspergillus niger var. awamori |
2002 |
10 |
Enzyme submission –derived from GM Aspergillus niger var. awamori |
2003 |
8 |
Hemicellulase Enzyme in bread-making |
1999 |
19 |
Immobilised lipase from Rhizopus niveus COT consideration of the safety-in-use of |
1994 |
9 |
COT consideration of additional data for |
1998 |
13 |
Lipase D Enzyme submission COT |
2000 |
16 |
Enzyme submission COT |
2001 |
9 |
Newlase analytical method to detect rhizoxin |
2000 |
17 |
Enzyme submission COT update, method review |
2002 |
11 |
Enzyme submission COT, |
2004 |
10 |
Enzyme Submission – Newlase analytical method to detect rhizoxin |
2004 |
10 |
Xylanase preparation from Aspergillus niger |
2001 |
13 |
Microbial enzyme preparations (safety assessment of) |
1991 |
17 |
Subject: Eosinophilia-myalgia syndrome, tryptophan and |
Year |
Page |
risk to health of tryptophan, particularly in food supplements. |
2003 |
21, 83 |
COT review of a contaminant in the tryptophan produced by one manufacturer |
2004 |
12 |
Subject: Epigenetics in carcinogenesis |
Year |
Page |
COC evaluation of |
2013 |
53 |
COC evaluation of |
2016 |
35 |
in chemical risk assessment, |
2017 |
54 |
in chemical risk assessment, |
2017 |
43 |
joint committee workshop on |
2018 |
42 |
Subject: Epoxidised soya bean oil |
Year |
Page |
COT evaluation of; TDI |
1994 |
8 |
COT evaluation of; updated guidance from 1994 report |
1999 |
16 |
Subject: Erythritol |
Year |
Page |
laxation |
2003 |
9 |
sensitivity of young children to polyols |
2004 |
9 |
Subject: Erythrosine |
Year |
Page |
COT review of |
1991 |
29 |
Subject: Ethaboxam |
Year |
Page |
partial COM review of |
2007 |
131 |
Subject: Ethanol (see also alcohol) |
Year |
Page |
acetaldehyde and alcoholic beverages |
2000 |
62 |
effects on pregnancy, reproduction and infant development |
1995 |
8 |
Subject: Exhaust, diesel |
Year |
Page |
Carcinogenicity of |
1991 |
47 |
Subject: Exposure Assessment |
Year |
Page |
Food chemicals, to |
2002 |
12 |
Less than lifetime |
2020 |
31 |
Statement on assessment of less than lifetime exposure |
2021 |
19 |
single or short term, to carcinogens |
2005 |
140 |
Draft EFSA Scientific Committee Opinion on scientific criteria for grouping chemicals into assessment groups for human risk assessment of combined exposure to multiple chemicals |
2021 |
26 |